Article
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Dec 2016
Balmaña Judith, Digiovanni Laura, Gaddam Pragna, Walsh Michael F, Joseph Vijai, Stadler Zsofia K, Nathanson Katherine L, Garber Judy E, Couch Fergus J, Offit Kenneth, Robson Mark E, Domchek Susan M
Abstract excerpt
Purpose Massively parallel sequencing allows simultaneous testing of multiple genes associated with cancer susceptibility. Guidelines are available for variant classification; however, interpretation of these guidelines by laboratories and providers may differ and lead to conflicting reporting and, potentially, to inappropriate medical management. We describe conflicting variant interpretations between Clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
